Probiotics and Probiotic Bacteria

Whether functional probiotic foods or beverages, probiotic supplements, topical applications and feed additives for use in animal health and livestock production, GanedenBC³⁰ (Bacillus coagulans GBI-30, 6086) and Ganeden's other probiotics can be used in a variety application that are impossible for other strains of probiotics.

Ganeden’s probiotic strains have been shown to be heartier than other probiotic strains and exhibits excellent stability, offering more flexibility in manufacturing and delivery systems – making them the probiotic solution you’ve been searching for.

The Problem: Traditional probiotics are inherently poor choices

• • Cells don’t survive high heat and pressure in the manufacturing process
• • Cells die quickly on the shelf
• • Few cells survive stomach acids to populate the gut
• • Cells are very sensitive to bile and various enzymes in the gut

The Solution: GanedenBC³⁰ and other Ganeden patented probiotic strains

• • GanedenBC³⁰ survives manufacturing process
• • GanedenBC³⁰ is shelf stable - no refrigeration required
• • GanedenBC³⁰ survive gastric acidity
• • GanedenBC³⁰ is safe - nearly 300 million individual doses sold
•   without a single reported adverse reaction
• • GanedenBC³⁰ is self-affirmed GRAS

Why Ganeden Labs’ probiotics have the probiotic advantage

Ganeden’s probiotic strains are pure, precise, patented strains of Bacillus coagulans that provide superior viability compared to other probiotic bacteria. Ganeden’s premier strain, GanedenBC³⁰ is patented, has been proven effective in dozens of human, animal and laboratory tests, is self-affirmed GRAS, Kosher and a non-GMO. Plus, with hundreds of millions of doses consumed, GanedenBC³⁰ has a proven track record of safety.

Ganeden is continually developing new, innovative and patented technologies and applications that are leading today’s functional food, beverage and nutraceutical markets. With its extensive patent portfolio, Ganeden Biotech has licenses in place with innovative companies worldwide – licensing its technology to create superior probiotic products in a variety of markets and applications.

To learn more about licensing opportunities, click here »

About Probiotics

Probiotics are defined by the World Health Organization (WHO) as living microorganisms, or good bacteria, which when administered in adequate amounts, confer a health benefit on the host.

In 2007, probiotic sales in the United States topped $700 million in the food and beverage market alone.

Consumers are driving the demand for probiotic products. Organizations interested in formulating products with probiotics are recognizing that probiotics must not only be backed by solid clinical data but for any probiotic to yield health benefits, the selected probiotic bacteria must survive the manufacturing process, the shelf life of the product and ultimately survive the passage through the digestive system to successfully colonize in the intestines.